Save the Saviors.
Medical practitioners should not need to risk their own health while saving the lives of others.
We have invented Texray the first radiation protection textile in the world. The textile is a patented technology platform and constitutes of a woven and breathable material with attenuating capacity and protects the user from harmful radiation and create peace of mind in the OR.
Saviors need saving too.
The benefits of X-ray guided interventions are immense and new products are continuously being introduced. For patients, it means procedures that are less invasive. For society, it means reduced healthcare costs due to shorter recovery time.
However – for medical practitioners, it means increased exposure to potentially harmful radiation. Having the best possible working environment is crucial in order to perform first-class surgery.
So Mrs Apell and Mr Gellerstedt decided to address this disparity. With more than 40 years of collective experiences in developing and distributing innovative products to the life science and healthcare sectors, they approached the challenge with open minds.
The first mission became clear: it was to develop a textile for radiation protection that would create peace of mind in the operating room.
CORPORATE TEAM
PETRA APELL
FOUNDER & CEO
Broad experiences based in Life sciences with start-ups, SMEs and global corporates Johnson & Johnson, XVIVO Perfusion, Mentice and Ortoma.
FREDRIK GELLERSTEDT
FOUNDER & CTO
Extensive experience in product, business development with Mölnlycke Healthcare, SCA Hygiene Products and Södra Skogsägarna.
NINA OFFEN LANTZ
CHIEF MARKETING OFFICER
Experienced marketing professional with demonstrated successful track-record from both global corporations and start-ups, within MedTech, Automotive and IT.
ANDREW WERNER
CHIEF OPERATIONS OFFICER
30 years in MedTech leadership at global corporations, with key roles like COO and SVP of Global Operations, blending a strategic and hands-on expertise.
TEXRAY BOARD
JEFFREY JUMP
CHAIRMAN OF THE BOARD
Over 40 years’ experience of the healthcare industry. Held several senior management positions at Cardio-Thoracic Systems, and Pfizer. Currently CEO and Chairman of MedAlliance (aq. by Cordis 2022).
PERNILLA LINDÈN
MEMBER OF THE BOARD
Extensive experience in product, business development with Mölnlycke Healthcare, SCA Hygiene Products and Södra Skogsägarna.
FREDRIK ODIN
MEMBER OF THE BOARD
Investment Director at Impilo. M.Sc in Finance and B.Sc in Economics, Politics and International Relations. Previously held positions at XIO Group in London, Bank of America Merrill Lynch and Lumenis
TOBIAS ELMQUIST
MEMBER OF THE BOARD
Senior investment manager at Industrifonden with 20 years of expertise in automotive, industrial, and logistics sectors. Previously key roles at Bure Equity, Volvo Group Venture Capital, Chalmers Ventures, and Maersk Growth.
